Comment on: Importance of selection and duration of antibiotic regimen in prosthetic joint infections treated with debridement and implant retention

被引：1
|
作者：
Dilworth, Thomas J. [1 ]
机构：
[1] Aurora St Lukes Med Ctr, Dept Pharm Serv, Milwaukee, WI 53215 USA
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2016年 / 71卷 / 12期
关键词：
D O I：
10.1093/jac/dkw339
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：3626 / 3627
页数：2
相关论文
共 50 条
  • [1] Importance of selection and duration of antibiotic regimen in prosthetic joint infections treated with debridement and implant retention
    Tornero, Eduard
    Morata, Laura
    Martinez-Pastor, Juan C.
    Angulo, Silvia
    Combalia, Andreu
    Bori, Guillem
    Garcia-Ramiro, Sebastian
    Bosch, Jordi
    Mensa, Josep
    Soriano, Alex
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (05) : 1395 - 1401
  • [2] Importance of selection and duration of antibiotic regimen in prosthetic joint infections treated with debridement and implant retention-authors' response
    Tornero, Eduard
    Soriano, Alex
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (12) : 3627 - 3627
  • [3] Debridement, Antibiotic Therapy, and Implant Retention in Staphylococcus aureus Prosthetic Joint Infections
    Krause, R.
    Hoenigl, M.
    Valentin, T.
    Zollner-Schwetz, I.
    [J]. CLINICAL INFECTIOUS DISEASES, 2013, 56 (12) : 1842 - 1843
  • [4] Debridement, Antibiotic Therapy, and Implant Retention in Staphylococcus aureus Prosthetic Joint Infections Reply
    Lora-Tamayo, Jaime
    Murillo, Oscar
    Ariza, Javier
    [J]. CLINICAL INFECTIOUS DISEASES, 2013, 56 (12) : 1843 - 1844
  • [5] Efficacy and safety of rifampin containing regimen for staphylococcal prosthetic joint infections treated with debridement and retention
    O. C. El Helou
    E. F. Berbari
    B. D. Lahr
    J. E. Eckel-Passow
    R. R. Razonable
    I. G. Sia
    A. Virk
    R. C. Walker
    J. M. Steckelberg
    W. R. Wilson
    A. D. Hanssen
    D. R. Osmon
    [J]. European Journal of Clinical Microbiology & Infectious Diseases, 2010, 29 : 961 - 967
  • [6] Efficacy and safety of rifampin containing regimen for staphylococcal prosthetic joint infections treated with debridement and retention
    El Helou, O. C.
    Berbari, E. F.
    Lahr, B. D.
    Eckel-Passow, J. E.
    Razonable, R. R.
    Sia, I. G.
    Virk, A.
    Walker, R. C.
    Steckelberg, J. M.
    Wilson, W. R.
    Hanssen, A. D.
    Osmon, D. R.
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2010, 29 (08) : 961 - 967
  • [7] Outcome of prosthetic joint infections treated with debridement and retention of components
    Marculescu, CE
    Berbari, EF
    Hanssen, AD
    Steckelberg, JM
    Harmsen, SW
    Mandrekar, JN
    Osmon, DR
    [J]. CLINICAL INFECTIOUS DISEASES, 2006, 42 (04) : 471 - 478
  • [8] Antibiotic therapy duration for prosthetic joint infections treated by Debridement and Implant Retention (DAIR): Similar long-term remission for 6 weeks as compared to 12 weeks
    Chaussade, Helene
    Uckay, Ilker
    Vuagnat, Albert
    Druon, Jerome
    Gras, Guillaume
    Rosset, Philippe
    Lipsky, Benjamin A.
    Bernard, Louis
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2017, 63 : 37 - 42
  • [9] KLIC-score for predicting early failure in prosthetic joint infections treated with debridement, implant retention and antibiotics
    Tornero, E.
    Morata, L.
    Martinez-Pastor, J. C.
    Bori, G.
    Climent, C.
    Garcia-Velez, D. M.
    Garcia-Ramiro, S.
    Bosch, J.
    Mensa, J.
    Soriano, A.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2015, 21 (08) : 786.e9 - 786.e17
  • [10] A Retrospective Review of the Clinical Experience of Linezolid with or Without Rifampicin in Prosthetic Joint Infections Treated with Debridement and Implant Retention
    Morata L.
    Senneville E.
    Bernard L.
    Nguyen S.
    Buzelé R.
    Druon J.
    Tornero E.
    Mensa J.
    Soriano A.
    [J]. Infectious Diseases and Therapy, 2014, 3 (2) : 235 - 243
12345